This project will probe interactions at the active sites of a variety of members of the Aspartyl Protease class of enzymes. These studies will contribute to our understanding of the mechanism of action of these enzymes. They will reveal differences in active site geometry and in secondary specificity. These objectives will be accomplished by the synthesis and characterization of a series of new peptide of new peptide substrates and new peptide inhibitors for these enzymes. These compounds will be assembled by solid phase peptide synthesis, purified by ion-exchange chromatography and reversed-phase high performance liquid chromatography, and characterized by peptide sequencing. The substrate series will have a -Phe-(NO2)Phe-reactive bond that has been shown to be hydrolyzed by these enzymes. The sequence of the octapeptide substrate and the inhbitors will be varied based on previous work with porcine pepsin and will include residues to enhance the solubilllty. The substrates will be examined by steady-state kinetics and by cryoenzymological techniques. The kinetic parameters of a variety of enzymes will be determined and the optimal substrate for each enzyme found. The inhibitors will be examined for this strength of binding to the various enzymes and for their kinetics of binding. Some of the inhibitors prepared will be designed to serve as transition state analogs for the Aspartyl Proteases. This design is based on a careful study of the active site features revealed by crystallographic methods.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases (NIADDK)
Type
Research Project (R01)
Project #
5R01AM018865-11
Application #
3151168
Study Section
Physiological Chemistry Study Section (PC)
Project Start
1978-06-01
Project End
1987-05-31
Budget Start
1985-06-01
Budget End
1986-05-31
Support Year
11
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Florida
Department
Type
Schools of Medicine
DUNS #
073130411
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Rao, C; Dunn, B M (1995) Evidence for electrostatic interactions in the S2 subsite of porcine pepsin. Adv Exp Med Biol 362:91-4
Lowther, W T; Dunn, B M (1995) Site-directed mutagenesis of rhizopuspepsin: an analysis of unique specificity. Adv Exp Med Biol 362:555-8
Kay, J; Dunn, B M (1990) Viral proteinases: weakness in strength. Biochim Biophys Acta 1048:1-18
Richards, A D; Phylip, L H; Farmerie, W G et al. (1990) Sensitive, soluble chromogenic substrates for HIV-1 proteinase. J Biol Chem 265:7733-6
Richards, A D; Roberts, R; Dunn, B M et al. (1989) Effective blocking of HIV-1 proteinase activity by characteristic inhibitors of aspartic proteinases. FEBS Lett 247:113-7
Pohl, J; Dunn, B M (1988) Secondary enzyme-substrate interactions: kinetic evidence for ionic interactions between substrate side chains and the pepsin active site. Biochemistry 27:4827-34
Dunn, B M; Valler, M J; Rolph, C E et al. (1987) The pH dependence of the hydrolysis of chromogenic substrates of the type, Lys-Pro-Xaa-Yaa-Phe-(NO2)Phe-Arg-Leu, by selected aspartic proteinases: evidence for specific interactions in subsites S3 and S2. Biochim Biophys Acta 913:122-30
Dunn, B M; Jimenez, M; Parten, B F et al. (1986) A systematic series of synthetic chromophoric substrates for aspartic proteinases. Biochem J 237:899-906
Dreyer, T; Valler, M J; Kay, J et al. (1985) The selectivity of action of the aspartic-proteinase inhibitor IA3 from yeast (Saccharomyces cerevisiae). Biochem J 231:777-9
Dunn, B M; Kay, J (1985) Design, synthesis and analysis of new synthetic substrates for the aspartic proteinases. Biochem Soc Trans 13:1041-3